Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
Immunovant (Nasdaq: IMVT) will report financial results for the second quarter ended September 30, 2025 and provide a business update on Monday, November 10, 2025 at 8:00 a.m. ET.
The company said investors can access the Roivant (Nasdaq: ROIV) conference call by phone after registering online and can view the presentation and live webcast via the Investors > News & Events section at https://www.immunovant.com/investors/news-events/ir-calendar. An archived webcast will be available on Immunovant’s website after the call.
Immunovant (Nasdaq: IMVT) comunicherà i risultati finanziari del secondo trimestre terminato 30 settembre 2025 e fornirà un aggiornamento sull'andamento aziendale lunedì 10 novembre 2025 alle 8:00 ET.
La società ha detto che gli investitori possono accedere alla conferenza telefonica Roivant (Nasdaq: ROIV) registrandosi online e possono visualizzare la presentazione e la diretta webcast tramite la sezione Investors > News & Events su https://www.immunovant.com/investors/news-events/ir-calendar. Una registrazione webcast sarà disponibile sul sito di Immunovant dopo la chiamata.
Immunovant (Nasdaq: IMVT) reportará los resultados financieros del segundo trimestre terminado el 30 de septiembre de 2025 y ofrecerá una actualización empresarial el lunes 10 de noviembre de 2025 a las 8:00 a.m. ET.
La compañía indicó que los inversionistas pueden acceder a la conferencia telefónica de Roivant (Nasdaq: ROIV) registrándose en línea y pueden ver la presentación y la retransmisión en vivo a través de la sección Investors > News & Events en https://www.immunovant.com/investors/news-events/ir-calendar. Se podrá ver una grabación de la webcast disponible en el sitio web de Immunovant tras la llamada.
Immunovant (Nasdaq: IMVT) 은 2025년 9월 30일에 종료된 2분기 재무실적을 발표하고 2025년 11월 10일 월요일 오전 8:00 ET에 비즈니스 업데이트를 제공합니다.
회사는 투자자들이 온라인으로 등록한 후 전화로 Roivant (Nasdaq: ROIV) 컨퍼런스 콜에 접속할 수 있으며, 프레젠테이션과 생방송 웹캐스트는 Investors > News & Events 섹션의 https://www.immunovant.com/investors/news-events/ir-calendar에서 시청할 수 있다고 말했습니다. 콜 이후 Immunovant 웹사이트에서 보관된 웹캐스트를 이용할 수 있습니다.
Immunovant (Nasdaq: IMVT) publiera les résultats financiers du deuxième trimestre clos le 30 septembre 2025 et fournira une mise à jour commerciale le Lundi 10 novembre 2025 à 8h00 ET.
Selon la société, les investisseurs pourront accéder à la conférence téléphonique Roivant (Nasdaq: ROIV) par téléphone après s'être inscrits en ligne et pourront visionner la présentation et le webcast en direct via la section Investors > News & Events sur https://www.immunovant.com/investors/news-events/ir-calendar. Un webcast archivé sera disponible sur le site d'Immunovant après l'appel.
Immunovant (Nasdaq: IMVT) wird die Finanzergebnisse des zweiten Quartals zum 30. September 2025 berichten und ein Geschäftsup-Date am Montag, den 10. November 2025 um 8:00 Uhr ET bereitstellen.
Das Unternehmen teilte mit, dass Investoren die Roivant-Konferenz telefonisch nach Online-Registrierung erreichen können und die Präsentation sowie der Live-Webcast über den Abschnitt Investors > News & Events unter https://www.immunovant.com/investors/news-events/ir-calendar ansehen können. Ein archivierter Webcast wird nach dem Anruf auf der Immunovant-Website verfügbar sein.
Immunovant (Nasdaq: IMVT) ستعلن عن النتائج المالية للربع الثاني المنتهي في 30 سبتمبر 2025 وتقدم تحديثاً للأعمال في يوم الإثنين، 10 نوفمبر 2025 الساعة 8:00 صباحاً بتوقيت شرق الولايات المتحدة.
قالت الشركة إن المستثمرين يمكنهم الوصول إلى مؤتمر Roivant (Nasdaq: ROIV) الهاتفي بعد التسجيل عبر الإنترنت ويمكنهم مشاهدة العرض التقديمي والبث المباشر من خلال قسم Investors > News & Events في https://www.immunovant.com/investors/news-events/ir-calendar. سيكون هناك بث مسجّل عبر الإنترنت متاح على موقع Immunovant بعد المكالمة.
Immunovant ( 纳斯达克股票代码: IMVT) 将公布截至2025年9月30日的第二季度财务业绩并在2025年11月10日星期一美国东部时间上午8:00提供业务更新。
公司表示，投资者在在线注册后可通过电话接入 Roivant (纳斯达克: ROIV) 的电话会议，并可通过Investors > News & Events栏目在https://www.immunovant.com/investors/news-events/ir-calendar查看演示文稿和直播网cast。电话会议结束后， Immunovant 的网站将提供归档网cast。
- None.
- None.
NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m. ET on Monday, November 10, 2025.
To access the Roivant (Nasdaq: ROIV) conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under “News & Events” in the Investors section of the Immunovant website at https://www.immunovant.com/investors/news-events/ir-calendar. The archived webcast will be available on Immunovant’s website after the conference call.
About Immunovant
Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For additional information on the Company, please visit immunovant.com.
Contacts:
Investors
Keyur Parekh
keyur.parekh@roivant.com
Media
Stephanie Lee
stephanie.lee@roivant.com
FAQ
When will Immunovant (IMVT) release Q2 2025 financial results and hold its business update?
How can investors join the Immunovant (IMVT) conference call on November 10, 2025?
Where will the Immunovant (IMVT) webcast and presentation be posted?
Will Immunovant (IMVT) make a recording of the November 10, 2025 call available?
Does the announcement mention any earnings figures or guidance for IMVT for Q2 2025?
